‘s Insider Buys
Odonate ODT’s Chairman and CEO Kevin Tang has made open market purchases of more than $36 million in so far this June, including $10 million on the spot secondary at the highest price his paid all year. This is a bet the farm investment but seems to be validated by the market as ODT stock has more than tripled this year. Three insiders buy AbbVie after Wall Street choked on their purchase of Allergan. Do two out of favor big pharma companies add up to 4? Wall Street certainly doesn’t think so. Carnival Cruise CEO Donald Arnold bought just under … Read more